Skip main navigation

Array CGH: Identifying chromosome dosage abnormalities

In this article, we will look at arrary CGH and how they identify chromosome abnormalities.
© Dr Meriel McEntagart, Consultant Clinical Geneticist, St George’s University Hospital NHS Foundation Trust

As we discussed earlier in the course, chromosomes are essentially packages of DNA.

To revise, humans have 46 chromosomes or 23 pairs, with one chromosome of each pair inherited from each parent. Pairs 1-22 are the same (called the autosomes) whilst the 23rd pair (the sex chromosomes) comprise two X chromosomes in a female and an X and a Y chromosome in a male.

Diagnostic laboratories have increasingly been using array CGH (array comparative genomic hybridisation) as the first line investigation for patients with intellectual disability, developmental delay, autism and congenital abnormalities. It is also being applied in the prenatal setting following the detection of ultrasound scanning abnormalities in the pregnancy.

Array CGH has superseded the previous technique of examining the chromosomes down a microscope. This is primarily because it interrogates the chromosomes at higher resolution detecting loss (deletions) or gain (duplications) of all or part of a chromosome down to less than 100kb (kb = kilo bases. 1 kilo base = 1000 bases of DNA).

However, array CGH cannot detect chromosome rearrangements such as balanced translocations which still require microscopic analysis, and is unable to identify DNA sequence changes of an individual gene. Such changes are identified by a different method called gene sequencing.

How does array CGH work?

The patient and reference DNA are labelled with different coloured fluorescent dyes and applied to an array slide on to which is spotted DNA representing the whole genome. The patient and reference DNA binds to the DNA on the slide.

Gains and losses of patient DNA can be detected by identifying differences in fluorescence between patient and reference samples (see Figure 1). We have also included a PDF version of Figure 1 in the downloads section below.

Array CGH: Identifying chromosome dosage abnormalities
Figure 1: The array comparative genomic hybridisation (array CGH) process Click to expand
© St George’s, University of London

Talking point

What would you imagine are the challenges of Array CGH in clinical practice? What do you think it can and can’t be used for?

Please post your comments and we’ll consider these questions further in the next couple of steps.

© Dr Meriel McEntagart, Consultant Clinical Geneticist, St George’s University Hospital NHS Foundation Trust
This article is from the free online

The Genomics Era: the Future of Genetics in Medicine

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education